Login to Your Account

Sanofi Uses $21.2B cash, CVR to Win Grande Dame Genzyme

By Tom Wall

Thursday, February 17, 2011
In the end, all it took was more cash now, and a shot at more cash later, for French suitor Sanofi-Aventis SA to win over Genzyme Corp., one of the grande dames of U.S. biotechnology.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription